UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

Leukemia, 2017-07, Vol.31 (7), p.1562-1569

2017

Volltextzugriff (PDF)

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.557-561

2013

Volltextzugriff (PDF)

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Leukemia, 2010-11, Vol.24 (11), p.1934-1939

2010

Volltextzugriff (PDF)

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

Leukemia, 2016-03, Vol.30 (3), p.633-639

2016

Volltextzugriff (PDF)

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

Kidney international, 2008-06, Vol.73 (11), p.1282-1288

2008

Volltextzugriff (PDF)

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

Leukemia, 2013-01, Vol.27 (1), p.220-225

2013

Volltextzugriff (PDF)

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Leukemia, 2017-01, Vol.31 (1), p.92-99

2017

Volltextzugriff (PDF)

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

Leukemia, 2016-05, Vol.30 (5), p.1079-1085

2016

Volltextzugriff (PDF)

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Leukemia, 2007-03, Vol.21 (3), p.529-534

2007

Volltextzugriff (PDF)

Second auto-SCT for treatment of relapsed multiple myeloma

Bone marrow transplantation (Basingstoke), 2013-04, Vol.48 (4), p.568-573

2013

Volltextzugriff (PDF)

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1302-1307

2013

Volltextzugriff (PDF)

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

Leukemia, 2015-10, Vol.29 (10), p.2033-2038

2015

Volltextzugriff (PDF)

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2009-04, Vol.43 (8), p.619-625

2009

Volltextzugriff (PDF)

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.970-975

2011

Volltextzugriff (PDF)

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

Leukemia, 2013-10, Vol.27 (10), p.2062-2066

2013

Volltextzugriff (PDF)

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1156-1158

2016

Volltextzugriff (PDF)

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1543-1547

2013

Volltextzugriff (PDF)

Impact of early relapse after auto-SCT for multiple myeloma

Bone marrow transplantation (Basingstoke), 2008-09, Vol.42 (6), p.413-420

2008

Volltextzugriff (PDF)

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.201-205

2014

Volltextzugriff (PDF)

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

Leukemia, 2012-05, Vol.26 (5), p.1119-1122

2012

Volltextzugriff (PDF)

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

Bone marrow transplantation (Basingstoke), 2013-12, Vol.48 (12), p.1543

2013

Volltextzugriff (PDF)

Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.996

2014

Volltextzugriff (PDF)

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.956-961

2011

Volltextzugriff (PDF)

Incidence of Cardiac Arrhythmias During Autologous Peripheral Blood Stem Cell Transplantation

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S207-S207

2012

Volltextzugriff (PDF)

Cardiomyopathy Following High Dose Melphalan Conditioning Prior to Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma and Primary Amyloidosis

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S203-S203

2011

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma

Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Second auto-SCT for treatment of relapsed multiple myeloma

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

Impact of early relapse after auto-SCT for multiple myeloma

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT

Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization

Incidence of Cardiac Arrhythmias During Autologous Peripheral Blood Stem Cell Transplantation

Cardiomyopathy Following High Dose Melphalan Conditioning Prior to Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma and Primary Amyloidosis

Suchergebnisse filtern